Literature DB >> 33279368

Barriers to Implementing Cardiovascular Risk Calculation in Primary Care: Alignment With the Consolidated Framework for Implementation Research.

Leah Tuzzio1, Ellen S O'Meara2, Erika Holden2, Michael L Parchman2, James D Ralston2, Jennifer A Powell3, Laura-Mae Baldwin4.   

Abstract

INTRODUCTION: Cardiovascular disease risk calculators can inform and guide preventive strategies and treatment decisions by clinicians and patients. However, their uptake in primary care has been slow despite the recommendation in national cardiovascular disease prevention guidelines. Identifying the barriers to the implementation of cardiovascular disease risk calculators is essential for promoting their adoption.
METHODS: The authors qualitatively analyzed structured physician educator notes written during an outreach education intervention with 44 small- and medium-sized primary care clinics that participated in the Agency for Healthcare Research and Quality‒funded EvidenceNOW Healthy Hearts Northwest trial. The authors coded barriers to the implementation of cardiovascular disease risk calculation and aligned them to the Consolidated Framework for Implementation Research.
RESULTS: The authors identified 13 barriers from the physician educators' notes. The majority (n=8, 62%) mapped to the framework's Inner Setting domain. The 5 most commonly noted barriers were (1) time constraints to use a calculator (N=23 clinics), (2) limitations to accessing a calculator or the necessary information to use a calculator (N=22 clinics), (3) no or minimal buy-in from clinicians or staff to use a calculator (N=19 clinics), (4) reported patient fear of side effects from statin medications or patient dislike of taking medications per the guidelines (N=17 clinics), and (5) lack of documented clinic workflow for using a calculator (N=16 clinics).
CONCLUSIONS: To improve the uptake of cardiovascular disease risk calculation in primary care, future cardiovascular disease prevention and implementation research should consider tailoring interventions to the common barriers to implementing cardiovascular disease risk calculation. TRIAL REGISTRATION: This study is registered at www.clinicaltrials.gov NCT02839382.
Copyright © 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33279368     DOI: 10.1016/j.amepre.2020.07.027

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  6 in total

1.  Concerning "The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health care".

Authors:  Javier Muñoz Laguna; Jose R Banegas
Journal:  Rev Panam Salud Publica       Date:  2022-07-04

2.  [The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health careO aplicativo HEARTS: uma ferramenta clínica para o gerenciamento de risco cardiovascular e hipertensão na atenção primária à saúde].

Authors:  Pedro Ordunez; Carlos Tajer; Thomas Gaziano; Yenny A Rodríguez; Andrés Rosende; Marc G Jaffe
Journal:  Rev Panam Salud Publica       Date:  2022-05-10

3.  ASPC president's page: Getting back to basics one patient at a time.

Authors:  Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2022-05-12

4.  "Patients would probably be more compliant to therapy if encouraged by those around them": a qualitative study exploring primary care physicians' perceptions on barriers to CVD risk management.

Authors:  Nikansha Kumar; Masoud Mohammadnezhad
Journal:  BMC Prim Care       Date:  2022-03-30

5.  The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health care.

Authors:  Pedro Ordunez; Carlos Tajer; Thomas Gaziano; Yenny A Rodriguez; Andres Rosende; Marc G Jaffe
Journal:  Rev Panam Salud Publica       Date:  2022-03-28

6.  Authors' response to the letter "Concerning The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health care".

Authors:  Pedro Ordunez; Carlos Tajer; Thomas Gaziano; Yenny A Rodriguez; Andres Rosende; Marc G Jaffe
Journal:  Rev Panam Salud Publica       Date:  2022-07-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.